Efficacy of Adding Bevacizumab in the First-Line Chemotherapy of Metastatic Colorectal Cancer: Evidence from Seven Randomized Clinical Trials

<table>Randomized effect model on HR of PFS in first-line chemotherapy. The beneficial HR of PFS in standard first-line chemotherapy is symbolized by a solid diamond at the bottom of the forest plot and the width of which represents the 95% CI.</table>

Gastroenterology Research and Practice

fig4

Figure 4

Figure 4: Efficacy of Adding Bevacizumab in the First-Line Chemotherapy of Metastatic Colorectal Cancer: Evidence from Seven Randomized Clinical Trials 

Figure 4 | Efficacy of Adding Bevacizumab in the First-Line Chemotherapy of Metastatic Colorectal Cancer: Evidence from Seven Randomized Clinical Trials 